| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72427 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76555-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49354-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-93026-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | MAB33541-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-62662-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89678-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81118-0.025mg | |||
![Western Blot: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTLA.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Western-Blot-NBP2-45549-img0015.jpg "Western Blot: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTLA.")
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0014.jpg)
![Flow Cytometry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of live Sup-B15 cells, using BTLA antibody , compared to IgG1 isotype control (Black).](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Flow-Cytometry-NBP2-45549-img0001.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0002.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0003.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0004.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0005.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0006.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0007.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0008.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0009.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0010.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0011.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0012.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (2E4) [NBP2-45549] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-2E4-Immunohistochemistry-NBP2-45549-img0013.jpg)
![Western Blot: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTLA.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Western-Blot-NBP2-72427-img0001.jpg "Western Blot: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTLA.")
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0014.jpg)
![Flow Cytometry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of live Sup-B15 cells, using BTLA antibody , compared to IgG1 isotype control (Black).](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Flow-Cytometry-NBP2-72427-img0002.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0003.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0004.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0005.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0006.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0007.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0008.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0009.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0010.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0011.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0012.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0013.jpg)
![Immunohistochemistry: BTLA/CD272 Antibody (OTI2E4) - Azide and BSA Free [NBP2-72427] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-OTI2E4-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72427-img0015.jpg)
![Western Blot: TOB2 Antibody [NBP2-24619] - Analysis of TOB2 in human heart lysate in the 1) absence and 2) presence of immunizing peptide using this antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/TOB2-Antibody-Western-Blot-NBP2-24619-img0001.jpg "Western Blot: TOB2 Antibody [NBP2-24619] - Analysis of TOB2 in human heart lysate in the 1) absence and 2) presence of immunizing peptide using this antibody at 5 ug/ml.")
![Western Blot: SLAM/CD150 Antibody [NBP1-76555] - Rat colon tissue lysate with SLAM antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Western-Blot-NBP1-76555-img0001.jpg "Western Blot: SLAM/CD150 Antibody [NBP1-76555] - Rat colon tissue lysate with SLAM antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunohistochemistry: SLAM/CD150 Antibody [NBP1-76555] - Immunohistochemistry of SLAMF1 in human colon tissue with SLAMF1 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Immunohistochemistry-NBP1-76555-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: SLAM/CD150 Antibody - BSA Free [NBP1-76555] - Immunofluorescence of SLAM/CD150 in human colon tissue with SLAM/CD150 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76555_rabbit-polyclonal-slam-cd150-antibody-2711202419592078.jpg)
![Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining of human tonsil shows moderate positivity in lymphoid cells.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-Immunohistochemistry-Paraffin-NBP2-49354-img0009.jpg "Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining of human tonsil shows moderate positivity in lymphoid cells.")
![Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining of human lung shows moderate cytoplasmic positivity in macrophages.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-Immunohistochemistry-Paraffin-NBP2-49354-img0006.jpg)
![Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining of human pancreas shows no cytoplasmic positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-Immunohistochemistry-Paraffin-NBP2-49354-img0007.jpg)
![Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining of human small intestine shows moderate positivity in lymphoid cells.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-Immunohistochemistry-Paraffin-NBP2-49354-img0008.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: BTLA/CD272 Antibody [NBP2-49354] - Staining in human tonsil and pancreas tissues . Corresponding BTLA RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-Immunohistochemistry-Paraffin-NBP2-49354-img0010.jpg)
![Western Blot: TOB2 Antibody [NBP2-93026] - Analysis of extracts of various cell lines, using TOB2 . Exposure time: 30s.](http://images.novusbio.com/fullsize/TOB2-Antibody-Western-Blot-NBP2-93026-img0003.jpg "Western Blot: TOB2 Antibody [NBP2-93026] - Analysis of extracts of various cell lines, using TOB2 . Exposure time: 30s.")
![Immunohistochemistry-Paraffin: TOB2 Antibody [NBP2-93026] - Paraffin-embedded mouse lung using TOB2 .](http://images.novusbio.com/fullsize/TOB2-Antibody-Immunohistochemistry-Paraffin-NBP2-93026-img0002.jpg)
![Immunohistochemistry-Paraffin: TOB2 Antibody [NBP2-93026] - Paraffin-embedded human liver damage using TOB2 .](http://images.novusbio.com/fullsize/TOB2-Antibody-Immunohistochemistry-Paraffin-NBP2-93026-img0001.jpg)
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody [NBP2-62662] - Staining of human thymus shows strong nuclear and cytoplasmic positivity in cortical and medullary cells.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Immunohistochemistry-Paraffin-NBP2-62662-img0003.jpg "Immunohistochemistry-Paraffin: SLAM/CD150 Antibody [NBP2-62662] - Staining of human thymus shows strong nuclear and cytoplasmic positivity in cortical and medullary cells.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: SLAM/CD150 Antibody [NBP2-62662] - Analysis in human lymph node and testis tissues using Anti-SLAMF1 antibody. Corresponding SLAMF1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Immunohistochemistry-Paraffin-NBP2-62662-img0001.jpg)
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody [NBP2-62662] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Immunohistochemistry-Paraffin-NBP2-62662-img0002.jpg)
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody [NBP2-62662] - Staining of human testis shows low expression as expected.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-Immunohistochemistry-Paraffin-NBP2-62662-img0004.jpg)
![Immunohistochemistry: TOB2 Antibody - BSA Free [NBP3-45166] - Immunohistochemistry of paraffin-embedded human liver injury tissue slide using ( TOB2 Antibody) at dilution of 1:100](http://images.novusbio.com/fullsize/nbp3-45166_rabbit-tob2-pab-bsa-free-284202511333234.jpg "Immunohistochemistry: TOB2 Antibody - BSA Free [NBP3-45166] - Immunohistochemistry of paraffin-embedded human liver injury tissue slide using ( TOB2 Antibody) at dilution of 1:100")
![Western Blot: TOB2 Antibody - BSA Free [NBP3-45166] - MCF7 cells were subjected to SDS PAGE followed by western blot with ( TOB2 Antibody) at dilution of 1:1000](http://images.novusbio.com/fullsize/nbp3-45166_rabbit-tob2-pab-bsa-free-284202511352262.jpg)
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody (8) [NBP2-89678] - Staining of human SLAMF1 in human appendix with rabbit monoclonal antibody (1:2000).](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-8-Immunohistochemistry-Paraffin-NBP2-89678-img0003.jpg "Immunohistochemistry-Paraffin: SLAM/CD150 Antibody (8) [NBP2-89678] - Staining of human SLAMF1 in human appendix with rabbit monoclonal antibody (1:2000).")
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody (8) [NBP2-89678] - Staining of human SLAMF1 in human tonsil with rabbit monoclonal antibody (1:2000).](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-8-Immunohistochemistry-Paraffin-NBP2-89678-img0001.jpg)
![Immunohistochemistry-Paraffin: SLAM/CD150 Antibody (8) [NBP2-89678] - Staining of human SLAMF1 in human lymph node with rabbit monoclonal antibody (1:2000).](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-8-Immunohistochemistry-Paraffin-NBP2-89678-img0002.jpg)
![Flow Cytometry: SLAM/CD150 Antibody (SLAM.4) - Azide Free [NBP2-62198] - Surface staining of CD150 in human peripheral blood with anti-CD150 (SLAM.4) PE.](http://images.novusbio.com/fullsize/SLAM-CD150-Antibody-SLAM-4-Azide-Free-Flow-Cytometry-NBP2-62198-img0001.jpg "Flow Cytometry: SLAM/CD150 Antibody (SLAM.4) - Azide Free [NBP2-62198] - Surface staining of CD150 in human peripheral blood with anti-CD150 (SLAM.4) PE.")
![ELISA: BTLA/CD272 Antibody (HMBT-6B2) - Chimeric [NBP2-81118] - ELISA of anti-BTLA antibody on BTLA-Fc fusion protein. Binding curves of the rabbit IgG chimeric version of the (NBP2-81118; red line) and isotype control (NBP2-52638, anti-Fluorescein; blue line) to an ELISA plate coated with BTLA-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10,000 to 0.17 ng/ml of NBP2-81118 was used. For signal detection, a 1:4000 dilution of anti-rabbit IgG1 antibody was used. The second increase in absorbance at 3333ng/ml is suggestive of a possible secondary binding epitope for NBP2-81118 on BTLA-Fc fusion protein.](http://images.novusbio.com/fullsize/BTLA-CD272-Antibody-HMBT-6B2-Chimeric-ELISA-NBP2-81118-img0001.jpg "ELISA: BTLA/CD272 Antibody (HMBT-6B2) - Chimeric [NBP2-81118] - ELISA of anti-BTLA antibody on BTLA-Fc fusion protein. Binding curves of the rabbit IgG chimeric version of the (NBP2-81118; red line) and isotype control (NBP2-52638, anti-Fluorescein; blue line) to an ELISA plate coated with BTLA-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10,000 to 0.17 ng/ml of NBP2-81118 was used. For signal detection, a 1:4000 dilution of anti-rabbit IgG1 antibody was used. The second increase in absorbance at 3333ng/ml is suggestive of a possible secondary binding epitope for NBP2-81118 on BTLA-Fc fusion protein.")